Bishal Gyawali, Medical Oncologist, Professor at Queen’s University, shared a post on X:
“Very exciting session on ctDNA going on at ASCO Breakthrough 2026 right now.
The conclusions from both the speakers are perfectly in line with our own conclusions recently published in JNCI on predictive vs. prognostic biomarkers.
Title: Critical appraisal: prognostic versus predictive surrogate markers in oncology
Authors: Aliyah Pabani, Bishal Gyawali
Other articles featuring Bishal Gyawali on OncoDaily.
